Abstract 2924: Preclinical analysis of synergistic antitumor effect of eribulin and HDAC inhibitor for triple-negative breast cancer cells

Author(s):  
Takaaki Oba ◽  
Hiroto Izumi ◽  
Ken-ichi Ito
2017 ◽  
Vol 24 (11) ◽  
pp. 1356-1367.e8 ◽  
Author(s):  
Thomas W. Hanigan ◽  
Shaimaa M. Aboukhatwa ◽  
Taha Y. Taha ◽  
Jonna Frasor ◽  
Pavel A. Petukhov

RSC Advances ◽  
2017 ◽  
Vol 7 (57) ◽  
pp. 36185-36192 ◽  
Author(s):  
Nursyamirah Abd Razak ◽  
M. Nadeem Akhtar ◽  
Nadiah Abu ◽  
Wan Yong Ho ◽  
Sheau Wei Tan ◽  
...  

BHMC possessedin vitroandin vivoantitumor effect on 4T1 triple negative breast cancer cells.


2017 ◽  
Vol 12 (1) ◽  
pp. 221-229
Author(s):  
Abeer M. Ashmawy ◽  
Mona A. Sheta ◽  
Faten Zahran ◽  
Abdel Hady A. Abdel Wahab

2021 ◽  
Vol 17 (4) ◽  
pp. 513-522
Author(s):  
Xuye Zhao ◽  
Xiangdong Bai ◽  
Weina Li ◽  
Xuezhen Gao ◽  
Xiaoli Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document